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Abstract
Background: Echocardiographic ratio of peak tricuspid regurgitant velocity to the right ventricular outflow tract time-
velocity integral (TRV/TVI rvot) was presented as a reliable non-invasive method of estimating pulmonary vascular 
resistance (PVR). Studies using this technique in patients with moderate to high PVR are scarce. Left ventricular outflow 
tract time-velocity integral (TVI lvot) can be easier to measure than TVI rvot, especially in patients with severe 
pulmonary hypertension (PH) with significant anatomical modifications of the right structures.
Aims: We wanted to determine whether the TRV/TVI rvot and TRV/TVI lvot ratios would form a reliable non-invasive 
tool to estimate PVR in a cohort of patients with moderate to severe pulmonary vascular disease.
Methods: Doppler echocardiographic examination and right heart catheterisation were performed in 37 patients. 
Invasive PVR was compared with TRV/TVI rvot and TRV/TVI lvot ratios using regression analysis. Two equations were 
modelled and the results compared with invasive measurements using the Bland-Altman analysis. Using receiver-
operating characteristics curve analysis, a cut-off value for the two ratios was generated.
Results: Correlation coefficients between invasive PVR and TRV/TVI rvot then TRV/TVI lvot were respectively 0.76 and 
0.74. Two new equations were found but the Bland-Altman analysis showed wide standard deviations (respectively 3.8 
and 3.9 Wood units). A TRV/TVI rvot then TRV/TVI lvot ratio cut-off value of 0.14 had a sensitivity of 93% and a specificity 
of 57% for the first and a sensitivity of 87% and a specificity of 57% for the second to determine PVR > 2 Wood units.
Conclusion: Echocardiography is useful for the screening of patients with pulmonary hypertension and PVR > 2 WU. It 
remains disappointing for accurate assessment of high PVR. TVI lvot may be an alternative to TVI rvot for patients for 
whom accurate TVI rvot measurement is not possible.
Introduction
Assessment of pulmonary vascular resistance (PVR) is
crucial in the diagnosis and management of cardio pul-
monary diseases such as pulmonary arterial hypertension
(PH). Invasive measurement of PVR by right heart cathe-
terisation remains the gold standard method [1,2].
Echocardiographic estimation of PVR using the ratio of
peak tricuspid regurgitant velocity (TRV) to the right
ventricular outflow tract time-velocity integral (TVI rvot)
was presented as a reliable non-invasive method to deter-
mine PVR [3]. While the ability of Doppler measurement
appeared criticable in patients with high PVR [4], few
studies have evaluated the TVR/TVI rvot ratio in these
cohorts of patients. Left ventricular outflow tract time-
velocity integral (TVI lvot) can be easier to measure than
TVI rvot, especially in patients with severe PH with
important anatomical modifications of the right struc-
tures which may make accurate measurements of the TVI
rvot difficult. Nevertheless TRV/TVI lvot was never
tested as an alternative to TRV/TVI rvot.
We aimed to determine whether the TRV/TVI rvot
ratio would form a reliable non-invasive tool to estimate
PVR in a cohort of patients with moderate to severe pul-
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monary vascular disease and whether TRV/TVI lvot ratio
could be an alternative.
Methods
Study population
Patients monitored in our Pulmonary Hypertension cen-
tre were prospectively recruited. All patients underwent
right-heart catheterisation within 24 hours (mean time: 6
hours) of the time of their echocardiography. Exclusion
criteria included tricuspid regurgitation grade > 2, intra-
cardiac shunt, aortic stenosis or aortic insufficiency grade
> 2 to avoid modifying the TVI rvot or TVI lvot measure-
ment. All subjects gave their written informed consent
for the participation to the study.
Cardiac catheterisation
Patients underwent standard right heart catheterisation
using a Swan-Ganz catheter with jugular or femoral
venous access. The following pressure measurements
were obtained: right atrial pressure (RAP), right ventricu-
lar pressure (RVP), pulmonary artery systolic pressure
(PASP), pulmonary artery diastolic pressure (PADP),
mean pulmonary artery pressure (MPAP) and right pul-
monary capillary wedge pressure (PCWP). Cardiac out-
put (Qp) was determined by thermodilution (mean of
three consecutive measurements without variation >
10%). The PVR was calculated using the formula: PVR =
(MPAP - PCWP)/Qp.
Echocardiography
Echocardiographic assessment was performed using a
Sonos 5500 ultrasound system (Philips®) equipped with
an S3 transducer, before catheterisation. The TVI rvot
(cm) was obtained by placing a pulsed wave Doppler sam-
ple volume just within the pulmonary valve from the
parasternal short axis view. TRV (m/s) was obtained
using continuous wave Doppler from apical 4-chamber,
parasternal and subcostal views and the highest peak
value was retained. TVI lvot was obtained from the apical
5-chamber view by placing a pulsed wave Doppler sample
volume in the left ventricular outflow tract just below the
a o r t i c  v a l v e .  TV I  rv o t  a n d  TV I  l v o t  w e r e  m e a s u r e d  3
times and averaged. Left ventricular ejection fraction
(LVEF) was assessed from an apical 4-chamber view
using the monoplane modified Simpson's rule. All mea-
surements were made off-line. The sonographer was
blinded to the results of cardiac catheterization. Contrast
echocardiography (e.g. agitated saline) was not used.
Statistical analysis
All statistical analyses were performed using StatView
version 5.0. Continuous variables were expressed as mean
± SD. Linear regression analysis was generated between
invasive PVR and TRV/TVI rvot and between invasive
PVR and TRV/TVI lvot, leading to Pearson's correlation
coefficient. Two equations derived from TRV/TVI rvot
and TRV/TVI lvot were obtained. The relation between
calculation of PVR by catheter measurements and Dop-
pler echocardiography with the two methods was
assessed by Bland-Altman analysis. Receiver operating
characteristic curves were generated to determine a cut-
off value for TRV/TVI rvot and for TRV/TVI lvot with
the best sensitivity to predict elevated PVR values (PVR >
2 WU). Linear regression analysis was realized between
invasive cardiac output and TVI rvot then TVI lvot, and
between invasive PASP and TRV, leading to Pearson's
correlation coefficient. 40% of the Doppler images were
re-evaluated to quantify the intra- and inter-observer
reliability by calculating the intraclass correlation coeffi-
cient.
Results
Overall, 37 consecutive patients (mean age 62 ± 12 years,
54% women) , diagnosed with pulmonary hypertension
were enrolled in this prospective cohort between June
2005 and December 2007. Mean PVR was 4.8 ± 3 Wood
units with preserved LVEF (mean LVEF: 66 ± 6%) and
cardiac output. Invasive haemodynamic data are shown
in Table 1. Referral diagnoses were idiopathic pulmonary
hypertension (n = 11), portopulmonary hypertension (n =
7), chronic thromboembolic pulmonary hypertension (n
= 6), pulmonary fibrosis (n = 5), systemic sclerosis (n = 5)
and chronic obstructive pulmonary disease (n = 3). Clini-
cal and echocardiographic data are resumed in Table 2.
Most patients presented dilated right atrium and ventri-
cle. Systolic velocity of the tricuspid annulus with Dop-
pler tissue imaging was lower to 11.5 cm/s in 16 patients.
Linear regression analysis between invasive PVR and
TRV/TVI rvot demonstrated good correlation for all
patients (r = 0.76; p < 0.0001). Similarly, good correlation
Table 1: Hemodynamic characteristics of the patients
Measurements Results
PASP (mmHg) 71 ± 24.7
PADP (mmHg) 24.3 ± 8.9
MPAP (mmHg) 37.5 ± 12.8
PCWP (mmHg) 11.6 ± 2.8
RAP (mmHg) 9.6 ± 4.8
PVR (WU) 4.8 ± 3
Cardiac Output (L/min) 5.7 ± 2
COPD: Chronic Obstructive Pulmonary Disease; MPAP: Mean 
Pulmonary Artery Pressure; PADP: Pulmonary Artery Diastolic 
Pressure; PASP: Pulmonary Artery Systolic Pressure; PCWP: 
Pulmonary Capillary Wedge Pressure; PVR: Pulmonary Vascular 
Resistances; WU: Wood units; RAP: Right Atrial Pressure. Results 
were expressed as mean ± SD.Roule et al. Cardiovascular Ultrasound 2010, 8:21
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was found between invasive PVR and TRV/TVI lvot (r =
0.74; p < 0.0001) for all patients (Figure 1, Panels A and
B).
The equations derived from these linear regressions
were:
Bland Altman analysis showed a homogeneous distri-
bution with a difference of ± 3.8 Wood units for the equa-
tion using VTI rvot and ± 3.9 Wood units for that using
VTI lvot (Figures 2, Panels A and B). A TRV/TVI rvot
cut-off value of 0.14 provided a sensitivity of 93% with a
specificity of 57% to determine PVR > 2 WU (area under
the curve = 0.85). The same cut-off value of 0.14 for the
ratio TRV/TVI lvot provided a sensitivity of 87% with a
specificity of 57% (area under the curve = 0.82) (Figure 3,
Panels A and B).
TRV in echocardiography and invasive PASP had a
good correlation (R = 0.8). Correlation between invasive
cardiac output and TVI rvot or TVI lvot was poor
(respectively R = 0.37 and R = 0.44).
The intraclass coefficient correlation for the intra- and
inter-observer reliabilities were 0.99 for both.
Discussion
We found that TRV/TVI rvot and TRV/TVI lvot deter-
mined by transthoracic echocardiography were signifi-
c a n t l y  c o r r e l a t e d  w i t h  i n v a s i v e  P V R  i n  a  c o h o r t  o f
patients with moderate and high PVR. However, the
agreement between PVR determined by echocardiogra-
phy and invasive PVR was poor.
Echocardiography plays a key role in the diagnosis,
prognosis and follow-up of patients with PH. PASP mea-
surement should ideally be completed by a PVR estima-
tion [5]. First proposal of Doppler assessment of PVR was
very interesting, showing excellent correlation with inva-
sive measurements in patients with near normal or mod-
erate level of right pressure and PVR [3]. Of the
echocardiographic methods used to assess PVR, equa- PVR TRV TVI rvot =× − 21 4 0 5 .( / ). (a)
PVR TRV TVI lvot =× − 32 8 1 8 .( / ). (b)
Figure 1 Linear regression analysis showing correlation between PVR by catheterization in Wood units (WU) and ratios TRV/TVI rvot (Panel 
A) and TRV/TVI lvot (Panel B) obtained by echocardiography. PVR = Pulmonary vascular resistance; TRV/TVI lvot = Peak tricuspid regurgitant ve-
locity/Left ventricular outflow tract time-velocity integral; TRV/TVI rvot = Peak tricuspid regurgitant velocity/Right ventricular outflow tract time-veloc-
ity integral; WU = Wood units.
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Table 2: Clinical and echocardiographic characteristics of 
the patients
Characteristics Results
WHO functional class:
- I n = 2
- II n = 16
- III n = 15
- IV n = 4
Rest rhythm:
- atrial fibrillation n = 5
- sinusal rhythm n = 32
RAP (mmHg) 8.3 ± 3.9
PASP (mmHg) 64 ± 19.5
Right atrial area (cm2) 21 ± 6
Right ventricular end-
diastolic diameter (cm)
3.8 ± 0.6
Tricuspid annular plane 
systolic excursion (cm)
2.1 ± 0.5
Systolic velocity of the 
tricuspid annulus (cm/s)
12.4 ± 2.8
PASP: Pulmonary Artery Systolic Pressure; RAP: Right Atrial 
Pressure.Roule et al. Cardiovascular Ultrasound 2010, 8:21
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tions using the ratio TRV/TVI rvot remain the simplest
and the most widely used. Nevertheless, studied in
patients with high pulmonary pressure and PVR levels,
t h e  a c c u r a c y  o f  t h i s  D o p p l e r  r a t i o  i n  a  p r a c t i c a l  d a i l y
activity was poor. In agreement with our results, TRV/
TVI rvot was reported to be correlated significantly with
invasively-determined PVR in populations with a similar
level of PVR [4,6]. Using a cut-off value of 0.14 for these
two ratios, patients with PVR greater than 2 Wood units
could be identified with high sensitivity but poor specific-
ity. This cut-off value remained close to previous values
reported by several studies using TRV/TVI rvot [3,4,7].
Figure 2 Bland Altman analysis showing the limits of agreement between PVR obtained by catheterization and PVR obtained by echocar-
diography with TVI rvot (Panel A) and with TVI lvot (Panel B). PVR = Pulmonary vascular resistance; TRV/TVI lvot = Peak tricuspid regurgitant ve-
locity/Left ventricular outflow tract time-velocity integral; TRV/TVI rvot = Peak tricuspid regurgitant velocity/Right ventricular outflow tract time-
velocity integral; WU = Wood units.
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Figure 3 Receiver operating characteristics (ROC) curves showing a sensitivity of 93% with a specificity of 57% for a TRV/TVI rvot cutoff val-
ue of 0.14 (Panel A, area under the curve = 0.85; p = 0.005) and a sensitivity of 87% with a specificity of 57% for a TRV/TVI lvot cutoff value 
of 0.14 (Panel B; area under the curve = 0.82; p = 0.009) to determine PVR > 2 WU. PVR = Pulmonary vascular resistance; TRV/TVI lvot = Peak 
tricuspid regurgitant velocity/Left ventricular outflow tract time-velocity integral; TRV/TVI rvot = Peak tricuspid regurgitant velocity/Right ventricular 
outflow tract time-velocity integral; WU = Wood units.
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While the TRV/TVI rvot may help to identify patients
who have high PVR, we failed to calculate the PVR pre-
cisely. The inaccuracy of echocardiography to determe
PVR was nevertheless emphasized, especially in patients
with severe PH. This may be explained by the accumula-
tion of potential sources of error in the estimation of PVR
by echocardiography in these patients. In case of severe
PH, in fact, small variations of TRV cause large changes
in PASP value (since the modified Bernoulli equation is
applied to TRV); and precise estimation of right atrial
pressure may be more difficult when it is high. Rajagol-
opan et al. used this method to demonstrate that there
was no linear or logarithmic relationship between TRV/
TVI rvot and PVR in patients with PVR > 8 Wood units
[4]. Only Abbas et al. were able to report good agreement
between invasive PVR and PVR evaluated by echocar-
diography in a cohort of patients less severe than ours
with a mean PVR of 2 Wood units [3]. The threshold of 2
WU to determine pulmonary arterial hypertension is
questionable and varies between studies [3-5,7-9]. Con-
sidering the weak specificity of PVR measurements by
echocardiography and the poor prognosis of patients
with PH, we think that it is important to choose the lower
limit in order to minimise the number of false negatives.
Our results did not demonstrate any advantage derived
by the use of both TVI rvot and TVI lvot. We estimate the
best practical approach remains the use of TVI rvot in
first intention as TRV/TVI rvot has more physiological
basis than TRV/TVI lvot. Correct alignment of the ultra-
sound beam is a vital factor to ensure adequate determi-
nation of TVI rvot. Sometimes anatomical variations of
the right-heart structures may make difficult accurate
measurements of the TVI rvot in patients with PH, with a
risk to introduce significant errors in right ventricular
stroke volume estimation. Using TVI lvot to estimate
right ventricular stroke volume may give more acurate
estimation and may be an alternative, provided that no
significant cardiac shunt or aortic valvulopathy are pres-
ent.
While TRV in echocardiography and invasive PASP had
a good correlation, correlation between invasive cardiac
output and Doppler measurement (ie TVI rvot , TVI lvot)
remained weak. Limits of our equations seems to be the
assimilation of TVI to the cardiac output and not local-
ization of its measurement. Contrary to a recent work
which considered heart rate to estimate non invasively
PVR [10], we did not take account the heart rate in equa-
tion. This may explain the low detected correlation
between the cardiac output and the TVI lvot or TVI rvot.
Right heart catheterisation is indicated in all patients
with suspected PH to confirm the diagnosis, assess the
severity and test the vasoreactivity of the pulmonary cir-
culation [2] but screening of these patients was previously
done by echocardiography. PASP and tricuspid regurgita-
tion velocity are recommanded for screening but could be
inaccurate in some patients [2,5]. Estimation of echocar-
diographic PVR with ours equations increases sensibility.
TVI rvot have to be used first being more validated in the
literature [3-7,10,11] but TVI lvot remains an alternative.
Limits
Echocardiography and right heart catheterization were
not performed simultaneously in this study. We tried to
minimize this potential source of error by performing the
echocardiography before the invasive measurements
under comparable loading conditions. Measurements of
cardiac output using thermodilution may be problematic
due to tricuspid regurgitation.We are aware of a quite sig-
nificant fraction of patient with severe pulmonary hyper-
tension were excluded of our study because of tricuspid
regurgitation grade > 2. As severe tricuspid regurgitation
is a well known pitfall of thermodilution cardiac output
measurement, we prefered exclude these patients in order
to obtain the most reliable invasive cardiac output.
Conclusion
While TRV/TVI rvot and TRV/TVI lvot determined by
transthoracic echocardiography significantly correlates
with invasive PVR, accurate measurement of PVR by
echocardiography remains disappointing, especially in
case of a high level of PH. However, echocardiography
can identify patients with PVR greater than 2 Wood units
with high sensitivity and remains a clinically useful tool
when screening patients with PH and high PVR.
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